A hybrid approach to AI is powering Amazon's Rufus shopping assistant and cutting-edge warehouse robots.

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), today announced that it will report its second quarter 2025 financial results on August 14, 2025. The Company will hold a conference call with the investment community on August 14, 2025, at 9:00 a.m. ET.

U.S.-China trade tensions remain a key chokehold for Nvidia Corporation and Advanced Micro Devices, Inc., whose growth upside hinges on the fate of whether and when they'll resume AI chip exports to China. Further complicating the situation is President Trump's recent imposition of a 15% revenue sharing program on related sales. This accordingly injects new downside risks to their forward growth estimates, countering potential over-optimism currently priced into their valuations following the mid-July reversal of China export curbs.

Jerash Holdings (US), Inc. (NASDAQ:JRSH ) Q1 2026 Earnings Conference Call August 12, 2025 9:00 AM ET Company Participants Eric Tang - Head of Operations of Jordan Gilbert Kwong-Yiu Lee - Chief Financial Officer Lin Hung Choi - Chairman, CEO, President & Treasurer Conference Call Participants Igor Novgorodtsev - Unidentified Company Mark Nicholas Argento - Lake Street Capital Markets, LLC, Research Division Michael Allen Baker - D.A. Davidson & Co., Research Division Roger S.

LNG signs long-term deal with JERA for supplying 1 mtpa of liquefied natural gas from 2029 to 2050, tied to Henry Hub prices.

Lam Research's early lead in ALD molybdenum tools positions it to gain share in advanced chipmaking for NAND and AI-driven logic.

RTX secures a DARPA cybersecurity contract and posts strong defense and aerospace gains, but supply-chain and valuation risks linger.

Applied Materials' diversified portfolio, resilient growth and lower valuation give it the edge over Lam Research in the AI-driven chip boom.

ConocoPhillips tops Q2 earnings estimates, boosts Marathon Oil resource outlook and eyes $2B in annual savings after full integration.

CB Financial Services (CBFV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 28.8% in Enerflex (EFXT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

After losing some value lately, a hammer chart pattern has been formed for German American Bancorp (GABC), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zymeworks (ZYME) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

After reaching an important support level, Rapt Therapeutics (RAPT) could be a good stock pick from a technical perspective. RAPT recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The consensus price target hints at a 27% upside potential for Carriage Services (CSV). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for a.k.a. Brands (AKA) points to an 84.7% upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 60.3% in SunOpta (STKL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 71.4% in VAREX IMAGING (VREX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.1% in Peloton (PTON). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.